Health-related quality of life in patients with moderate to severe psoriasis: Effects of treatment with ABT-874 versus etanercept or placebo

被引：0
作者：
Crowley, Jeffrey [1 ]
Yang, Hongbo [2 ]
Sundaram, Murali [3 ]
Mulani, Parvez [3 ]
机构：
[1] Bakersfield Dermatol, Bakersfield, CA USA
[2] Anal Grp, Boston, MA USA
[3] Abbott Labs, Abbott Pk, IL 60064 USA
来源：
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY | 2011年 / 64卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
引用
收藏
页码：AB160 / AB160
页数：1
相关论文
共 50 条
[21]   Comorbid psoriatic arthritis significantly impairs health-related quality of life in patients with moderate to severe psoriasis [J].
Kimball, Alexa B. ;
Sundaram, Murali ;
Signorovitch, James ;
Yang, Min ;
Taska, Bledi .
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2015, 72 (05) :AB228-AB228
[22]   The relationship between obesity and health-related quality of life in patients with moderate to severe psoriasis or rheumatoid arthritis [J].
Eisenberg, D. F. ;
Hanlon, A. ;
Segal, J. .
VALUE IN HEALTH, 2007, 10 (03) :A20-A20
[23]   Moderate to severe psoriasis patients' subjective future expectations regarding health-related quality of life and longevity [J].
Rencz, F. ;
Hollo, P. ;
Karpati, S. ;
Pentek, M. ;
Remenyik, E. ;
Szegedi, A. ;
Balogh, O. ;
Heredi, E. ;
Herszenyi, K. ;
Jokai, H. ;
Brodszky, V. ;
Gulacsi, L. .
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2015, 29 (07) :1398-1405
[24]   Association between clinical response and health-related quality of life outcomes for patients with moderate to severe psoriasis [J].
Revicki, Dennis ;
Menter, Alan ;
Saurat, Jean ;
Kaul, Martin .
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2008, 58 (02) :AB128-AB128
[25]   Etanercept treatment leads to rapid and sustained improvements in the quality of life of patients with moderate to severe psoriasis [J].
Feldman, S ;
Kimball, A ;
Woolley, J ;
Zitnik, R .
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2004, 122 (03) :A55-A55
[26]   Ixekizumab impact on health-related quality of life compared to etanercept and placebo: Results from UNCOVER-2, a phase 3 trial in patients with moderate-to-severe plaque psoriasis [J].
Reich, Kristian ;
Toth, Darryl ;
Nikai, Enkeleida ;
Zhu, Baojin ;
Carlier, Hilde ;
Feldman, Steven .
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2015, 135 :S35-S35
[27]   Health-Related Quality of Life in Patients Poststroke: Dapsone Versus Placebo [J].
Cruz-Cruz, Copytzy ;
Altagracia-Martinez, Marina ;
Kravzov-Jinich, Jaime ;
Rios-Castaneda, Camilo ;
Manuel Martinez-Nunez, Juan ;
Perez, Mirza E. .
JOURNAL OF PHARMACY TECHNOLOGY, 2012, 28 (03) :95-99
[28]   Health-Related Quality of Life in Patients with Psoriasis [J].
Jankovic, Slavenka ;
Raznatovic, Milena ;
Marinkovic, Jelena ;
Jankovic, Janko ;
Kocev, Nikola ;
Tomic-Spiric, Vesna ;
Vasiljevic, Nadja .
JOURNAL OF CUTANEOUS MEDICINE AND SURGERY, 2011, 15 (01) :29-36
[29]   Long-term safety and efficacy of ABT-874 for the treatment of moderate to severe psoriasis: Interim analysis from an open-label extension study [J].
Langley, Richard ;
Valdes, Joaquin ;
Gordon, Kenneth ;
Papp, Kim .
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2011, 64 (02) :AB148-AB148
[30]   Effects of methotrexate and etanercept treatment in moderate and severe psoriasis [J].
Benites, Elizabeth ;
Carrillo, Esmeralda ;
Heras, Martha .
MEDICINE, 2022, 101 (45) :E31527
12345